PROFITELLIGENCE/Guest access
!
Financial disclaimer

Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.

Legal agreement

By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.

i
Guest mode

You're browsing as a guest. Some features like watchlists and alerts require a free account.

--:--:--
Guest mode— viewing HCA. Sign up free to access all symbols.Sign up
HCA logo

HCA

HCA Healthcare Inc.

HealthcareMedical Care Facilities

Price performance

Sep 18, 2026
$427.71
$1.33-0.31%
1M
+5.08%
3M
+14.00%
YTD
-9.07%
vs SPY
+5.40%
30d range
396–437
Volatility
26.89%
Signals
Price chart

Company activity

34 events
Company activity
TimeTickerTypeEventQtyPriceValue
07/29HCA8-KHCA Inc. Increases Commercial Paper Program Size
07/24HCA8-KHCA Healthcare Announces Second Quarter 2026 Results and Dividend
07/14HCA8-KHCA Healthcare Revises 2026 Guidance Due to Payer Mix Shift
06/18HCA8-KDr. Michael Cuffe to Step Down as Chief Clinical Officer at HCA Healthcare
04/30HCA8-KHCA Healthcare Inc. Issues $3 Billion in Senior Notes
04/28HCA8-KHCA Healthcare Elects New Board Members and Ratifies Auditor
04/27HCA8-KHCA Healthcare Announces Proposed Public Offering of Senior Notes
04/24HCA8-KHCA Healthcare Reports Q1 2026 Results and Declares Quarterly Dividend
02/25HCA8-KBoard Member Robert J. Dennis to Retire from HCA Healthcare's Board
01/27HCA8-KHCA Healthcare Announces Q4 2025 Results and New Share Repurchase Program
10/31/25HCA8-KHCA Healthcare Announces $3.25 Billion Senior Notes Issuance
10/27/25HCA8-KHCA Healthcare Announces Proposed Public Offering of Senior Notes and Redemption of Existing Notes
10/24/25HCA8-KHCA Healthcare Reports Strong Q3 2025 Results and Raises Guidance
07/25/25HCA8-KHCA Healthcare Reports Strong Q2 2025 Financial Results and Raises Guidance
07/11/25HCA8-KHCA Healthcare Appoints John W. Chidsey, III as New Independent Director
06/10/25HCA8-KHCA Inc. Establishes New $4.0 Billion Commercial Paper Program
04/29/25HCA8-KHCA Healthcare Announces Director Compensation and Stock Incentive Plan Approval
04/25/25HCA8-KHCA Healthcare Reports Strong Q1 2025 Financial Results and Dividend Declaration
02/24/25HCA8-KBoard Member Retirement and Executive Performance Program Update
02/21/25HCA8-KHCA Inc. Completes $5.25B Senior Notes Offering
02/20/25HCA8-KHCA Healthcare Refinances Credit Facilities with New Agreement
02/18/25HCA8-KHCA Healthcare Announces Proposed Public Offering of Senior Notes
01/24/25HCA8-KHCA Healthcare Announces Financial Results and Board Actions
10/25/24HCA8-KHCA Healthcare Announces Q3 2024 Results and Quarterly Dividend
08/12/24HCA8-KHCA Healthcare, Inc. Announces Issuance of $3 Billion in Senior Notes
08/08/24HCA8-KHCA Healthcare Announces Underwriting Agreement for $3 Billion Senior Notes Issuance
07/23/24HCA8-KHCA Healthcare Reports Strong Q2 2024 Results and Raises Guidance
04/30/24HCA8-KHCA Healthcare Announces CFO Retirement and Board Elections
04/26/24HCA8-KHCA Healthcare Announces Strong Q1 2024 Results
02/26/24HCA8-KHCA Healthcare Updates Compensation for New CFO Michael A. Marks
02/26/24HCA8-KHCA Healthcare Announces New Executive Officer Performance Excellence Program and Appointments
02/23/24HCA8-KHCA Healthcare, Inc. Announces Issuance of $4.5 Billion Senior Notes
02/21/24HCA8-KHCA Healthcare Announces Underwriting Agreement for Senior Notes Issuance
01/30/24HCA8-KHCA Healthcare Reports Q4 2023 Results and Key Changes

HCA filing record

HCA Healthcare Inc. (HCA): 34 8-K filings summarized, the most recent on Jul 29, 2026.

What the 8-K filings said

  1. Jul 29, 2026 · medium impact

    On July 29, 2026, HCA Inc., a subsidiary of HCA Healthcare, Inc., increased the size of its commercial paper program from $4.0 billion to $8.0 billion. The commercial paper notes are guaranteed by the parent company and are not registered under the Securities Act of 1933. This increase allows the company to issue more…

    HCA Inc. Increases Commercial Paper Program Size
  2. Jul 24, 2026 · medium impact

    HCA Healthcare, Inc. reported second quarter 2026 results with revenues increasing 8.7% to $20.230 billion and net income attributable to HCA Healthcare, Inc. rising 2.8% to $1.699 billion. Diluted earnings per share increased 11.6% to $7.62. The company also announced a quarterly cash dividend of $0.78 per share…

    HCA Healthcare Announces Second Quarter 2026 Results and Dividend
  3. Jul 14, 2026 · high impact

    HCA Healthcare, Inc. announced preliminary results for the second quarter of 2026 and revised its 2026 guidance due to an unfavorable payer mix shift driven by an increase in uninsured volume and a service mix shift related to a decline in surgical volume. The company anticipates revenues of approximately $20.230…

    HCA Healthcare Revises 2026 Guidance Due to Payer Mix Shift
  4. Jun 18, 2026 · high impact

    On June 15, 2026, Dr. Michael Cuffe agreed to step down as Executive Vice President and Chief Clinical Officer of HCA Healthcare, Inc. effective August 31, 2026. He will continue in a transitional role until February 2027 and will be eligible for benefits under the Company's executive severance policy and applicable…

    Dr. Michael Cuffe to Step Down as Chief Clinical Officer at HCA Healthcare
  5. Apr 30, 2026 · medium impact

    On April 30, 2026, HCA Inc., a subsidiary of HCA Healthcare, Inc., completed the issuance of $3,000,000,000 aggregate principal amount of senior notes due in 2031, 2033, and 2036. The notes, guaranteed by HCA Healthcare, Inc., were issued under an indenture and will pay interest semi-annually. This issuance is part of…

    HCA Healthcare Inc. Issues $3 Billion in Senior Notes

SEC filings in the last five years

  • 54 Form 8-K
  • 13 Form 10-Q
  • 5 Form 10-K
  • 2 Form 8-K/A